Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
5.49
+0.04 (0.73%)
At close: Apr 28, 2026, 4:00 PM EDT
5.49
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $47.53 million as of April 28, 2026. Its market cap has decreased by -37.62% in one year.
Market Cap
47.53M
Enterprise Value
5.63M
1-Year Change
-37.62%
Ranking
Category
Stock Price
$5.49
Market Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has decreased from $62.00M to $47.53M, a decrease of -23.33%. That is a compound annual growth rate of -1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 46.90M | -38.45% |
| Dec 31, 2025 | 76.20M | -35.86% |
| Dec 31, 2024 | 118.80M | 7.71% |
| Dec 29, 2023 | 110.30M | 64.87% |
| Dec 30, 2022 | 66.90M | -66.98% |
| Dec 31, 2021 | 202.60M | 197.94% |
| Dec 31, 2020 | 68.00M | 375.52% |
| Dec 31, 2019 | 14.30M | 146.55% |
| Dec 31, 2018 | 5.80M | -17.14% |
| Dec 29, 2017 | 7.00M | 32.08% |
| Dec 30, 2016 | 5.30M | -45.36% |
| Dec 31, 2015 | 9.70M | -72.36% |
| Dec 31, 2014 | 35.10M | -16.03% |
| Dec 31, 2013 | 41.80M | -17.06% |
| Dec 31, 2012 | 50.40M | -18.71% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 52.22M |
| Radiopharm Theranostics | 50.62M |
| PDS Biotechnology | 50.26M |
| Nutriband | 48.57M |
| Telomir Pharmaceuticals | 48.13M |
| Xilio Therapeutics | 48.05M |
| Hyperion DeFi | 47.50M |
| Rein Therapeutics | 46.54M |